These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16408099)
1. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Kiladjian JJ; Bourgeois E; Lobe I; Braun T; Visentin G; Bourhis JH; Fenaux P; Chouaib S; Caignard A Leukemia; 2006 Mar; 20(3):463-70. PubMed ID: 16408099 [TBL] [Abstract][Full Text] [Related]
2. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes. Kiladjian JJ; Visentin G; Viey E; Chevret S; Eclache V; Stirnemann J; Bourhis JH; Chouaib S; Fenaux P; Caignard A Haematologica; 2008 Mar; 93(3):381-9. PubMed ID: 18268282 [TBL] [Abstract][Full Text] [Related]
3. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome. Carlsten M; Baumann BC; Simonsson M; Jädersten M; Forsblom AM; Hammarstedt C; Bryceson YT; Ljunggren HG; Hellström-Lindberg E; Malmberg KJ Leukemia; 2010 Sep; 24(9):1607-16. PubMed ID: 20613786 [TBL] [Abstract][Full Text] [Related]
4. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients. Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000 [TBL] [Abstract][Full Text] [Related]
5. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells. Condiotti R; Nagler A Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131 [TBL] [Abstract][Full Text] [Related]
6. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome]. Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955 [TBL] [Abstract][Full Text] [Related]
7. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). De Maria A; Fogli M; Costa P; Murdaca G; Puppo F; Mavilio D; Moretta A; Moretta L Eur J Immunol; 2003 Sep; 33(9):2410-8. PubMed ID: 12938217 [TBL] [Abstract][Full Text] [Related]
8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels. Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895 [TBL] [Abstract][Full Text] [Related]
10. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. Huenecke S; Zimmermann SY; Kloess S; Esser R; Brinkmann A; Tramsen L; Koenig M; Erben S; Seidl C; Tonn T; Eggert A; Schramm A; Bader P; Klingebiel T; Lehrnbecher T; Passweg JR; Soerensen J; Schwabe D; Koehl U J Immunother; 2010; 33(2):200-10. PubMed ID: 20145545 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation. Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells. Pintaric M; Gerner W; Saalmüller A Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242 [TBL] [Abstract][Full Text] [Related]
13. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor. Chang WC; Hsiao MH; Pattengale PK Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400 [TBL] [Abstract][Full Text] [Related]
17. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Epling-Burnette PK; Bai F; Painter JS; Rollison DE; Salih HR; Krusch M; Zou J; Ku E; Zhong B; Boulware D; Moscinski L; Wei S; Djeu JY; List AF Blood; 2007 Jun; 109(11):4816-24. PubMed ID: 17341666 [TBL] [Abstract][Full Text] [Related]
18. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431 [TBL] [Abstract][Full Text] [Related]
19. Induction of natural killer effectors from human thymus with recombinant IL-2. Michon JM; Caligiuri MA; Hazanow SM; Levine H; Schlossman SF; Ritz J J Immunol; 1988 May; 140(10):3660-7. PubMed ID: 3258886 [TBL] [Abstract][Full Text] [Related]
20. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]